V

Vimian Group AB
STO:VIMIAN

Watchlist Manager
Vimian Group AB
STO:VIMIAN
Watchlist
Price: 44.3 SEK 1.26% Market Closed
Market Cap: 22.9B SEK
Have any thoughts about
Vimian Group AB?
Write Note

Vimian Group AB
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vimian Group AB
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
V
Vimian Group AB
STO:VIMIAN
Operating Income
€39.4m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Operating Income
-kr88.5m
CAGR 3-Years
-2%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Operating Income
kr56.8m
CAGR 3-Years
N/A
CAGR 5-Years
46%
CAGR 10-Years
20%
D
Doxa AB
STO:DOXA
Operating Income
-kr7.5m
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
10%
Bactiguard Holding AB
STO:BACTI B
Operating Income
-kr118m
CAGR 3-Years
-128%
CAGR 5-Years
-76%
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Operating Income
kr2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Vimian Group AB
Glance View

Market Cap
23.1B SEK
Industry
Health Care

Vimian Group AB operates as an animal health company. The company is headquartered in Stockholm, Stockholm and currently employs 1,068 full-time employees. The company went IPO on 2021-06-18. The firm is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The firm invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.

VIMIAN Intrinsic Value
45.68 SEK
Undervaluation 3%
Intrinsic Value
Price
V

See Also

What is Vimian Group AB's Operating Income?
Operating Income
39.4m EUR

Based on the financial report for Sep 30, 2024, Vimian Group AB's Operating Income amounts to 39.4m EUR.

What is Vimian Group AB's Operating Income growth rate?
Operating Income CAGR 3Y
23%

Over the last year, the Operating Income growth was -21%. The average annual Operating Income growth rates for Vimian Group AB have been 23% over the past three years .

Back to Top